Clinical trial · Observational
Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors
NCT05124964CI-TRIAL-00055103recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary purpose of this study is to characterize the quality of life in patients with intracranial germ cell tumors. Those findings can contribute towards a better understanding of the impact of the current treatment strategy on survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chinese Wechsler Intelligence Scale for Children | Other | — | UNRESOLVED |
| PedsQL 4.0 Scale | Other | — | UNRESOLVED |
| Short Form-36 | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Patients with newly diagnosed primary intracranial germ cell tumors are scheduled for subsequent anti-tumor therapy.
- interventionNames
- Other: PedsQL 4.0 Scale
- Other: Short Form-36
- Other: Chinese Wechsler Intelligence Scale for Children
Primary outcomes (1)
- measure
- Change of score of the QoL questionnaire (PedsQL 4.0 : Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales, Chinese edition)
- timeFrame
- Evaluation will be evaluated at baseline, yearly through 3 years post-enrolment.
- description
- The PedsQL 4.0 Generic Core Scale contains 23 items that measures physical (eight items), emotional (five items), social (five items), and school (five items) functions. The Scale comprises parallel patient self-report and parent proxy-report formats. The items are reverse-scored and trans- formed to a 0-100 scale according to the instructions, and higher scores indicate a better HRQOL. (age ≤18 years)
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 30 Years
Show eligibility criteria text
Inclusion Criteria: * 3 years ≤ age ≤ 21 years * Newly diagnosed primary intracranial germ cell tumors * Written informed consent Exclusion Criteria: * Relapsed disease * Poor compliance
References
Publications (0)
Data not yet available
No reference posted for this study.